Making Sense Of Blood-based Proteomics And Metabolomics In Psychiatric Research

dc.creatorGuest
dc.creatorPaul C.; Guest
dc.creatorFrancesca L.; Martins-de Souza
dc.creatorDaniel
dc.date2016
dc.datejun
dc.date2017-11-13T13:20:32Z
dc.date2017-11-13T13:20:32Z
dc.date.accessioned2018-03-29T05:54:09Z
dc.date.available2018-03-29T05:54:09Z
dc.identifierInternational Journal Of Neuropsychopharmacology. Oxford Univ Press, v. 19, p. , 2016.
dc.identifier1461-1457
dc.identifier1469-5111
dc.identifierWOS:000383906700006
dc.identifier10.1093/ijnp/pyv138
dc.identifierhttps://academic.oup.com/ijnp/article-lookup/doi/10.1093/ijnp/pyv138
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/327646
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1364671
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionThis manuscript describes the basics of proteomic and metabolic profiling of blood serum and plasma from patients with psychiatric disorders. It will also explain the rationale behind the use of these bodily fluids, due to the need for user-friendly and rapid tests in clinics with simple sampling procedures. It has become evident over the last 15 years or so that psychiatric disorders are whole-body diseases and the bloodstream is a means of molecular transport that therefore provides a conduit for two-way communication with the brain. Here we also describe some of the basic biomarker findings from studies of serum or plasma from patients with psychiatric disorders like schizophrenia, major depression, and bipolar disorder. Finally, we will discuss potential future advancements in this area, which include the development of hand-held devices containing miniature proteomic and metabolic assays which can be used for facilitating diagnoses in a point-of-care setting and yield results in less than 15 minutes from a single drop of blood.
dc.description19
dc.description6
dc.descriptionFAPESP (Sao Paulo Research Foundation) [13/08711-3]
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageEnglish
dc.publisherOxford Univ Press
dc.publisherOxford
dc.relationInternational Journal of Neuropsychopharmacology
dc.rightsfechado
dc.sourceWOS
dc.subjectBiomarker
dc.subjectMetabolomics
dc.subjectProteomics
dc.subjectPsychiatric Disorders
dc.subjectSerum
dc.titleMaking Sense Of Blood-based Proteomics And Metabolomics In Psychiatric Research
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución